Literature DB >> 27247418

Multidimensional structure-function relationships in human β-cardiac myosin from population-scale genetic variation.

Julian R Homburger1, Eric M Green2, Colleen Caleshu3, Margaret S Sunitha4, Rebecca E Taylor5, Kathleen M Ruppel6, Raghu Prasad Rao Metpally7, Steven D Colan8, Michelle Michels9, Sharlene M Day10, Iacopo Olivotto11, Carlos D Bustamante12, Frederick E Dewey13, Carolyn Y Ho14, James A Spudich15, Euan A Ashley16.   

Abstract

Myosin motors are the fundamental force-generating elements of muscle contraction. Variation in the human β-cardiac myosin heavy chain gene (MYH7) can lead to hypertrophic cardiomyopathy (HCM), a heritable disease characterized by cardiac hypertrophy, heart failure, and sudden cardiac death. How specific myosin variants alter motor function or clinical expression of disease remains incompletely understood. Here, we combine structural models of myosin from multiple stages of its chemomechanical cycle, exome sequencing data from two population cohorts of 60,706 and 42,930 individuals, and genetic and phenotypic data from 2,913 patients with HCM to identify regions of disease enrichment within β-cardiac myosin. We first developed computational models of the human β-cardiac myosin protein before and after the myosin power stroke. Then, using a spatial scan statistic modified to analyze genetic variation in protein 3D space, we found significant enrichment of disease-associated variants in the converter, a kinetic domain that transduces force from the catalytic domain to the lever arm to accomplish the power stroke. Focusing our analysis on surface-exposed residues, we identified a larger region significantly enriched for disease-associated variants that contains both the converter domain and residues on a single flat surface on the myosin head described as the myosin mesa. Notably, patients with HCM with variants in the enriched regions have earlier disease onset than patients who have HCM with variants elsewhere. Our study provides a model for integrating protein structure, large-scale genetic sequencing, and detailed phenotypic data to reveal insight into time-shifted protein structures and genetic disease.

Entities:  

Keywords:  genetic burden; hypertrophic cardiomyopathy; myosin; rare disease genetics

Mesh:

Substances:

Year:  2016        PMID: 27247418      PMCID: PMC4914177          DOI: 10.1073/pnas.1606950113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  Mutation of the myosin converter domain alters cross-bridge elasticity.

Authors:  Jan Köhler; Gerhard Winkler; Imke Schulte; Tim Scholz; William McKenna; Bernhard Brenner; Theresia Kraft
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  ModLoop: automated modeling of loops in protein structures.

Authors:  András Fiser; Andrej Sali
Journal:  Bioinformatics       Date:  2003-12-12       Impact factor: 6.937

3.  Structure validation by Calpha geometry: phi,psi and Cbeta deviation.

Authors:  Simon C Lovell; Ian W Davis; W Bryan Arendall; Paul I W de Bakker; J Michael Word; Michael G Prisant; Jane S Richardson; David C Richardson
Journal:  Proteins       Date:  2003-02-15

4.  Mutations profile in Chinese patients with hypertrophic cardiomyopathy.

Authors:  Lei Song; Yubao Zou; Jizheng Wang; Zhimin Wang; Yisong Zhen; Kejia Lou; Qian Zhang; Xiaojian Wang; Hu Wang; Jia Li; Rutai Hui
Journal:  Clin Chim Acta       Date:  2005-01       Impact factor: 3.786

5.  Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease.

Authors:  B Yu; N A Sawyer; M Caramins; Z G Yuan; R B Saunderson; R Pamphlett; D R Richmond; R W Jeremy; R J Trent
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

Review 6.  Myosins: tails (and heads) of functional diversity.

Authors:  Mira Krendel; Mark S Mooseker
Journal:  Physiology (Bethesda)       Date:  2005-08

7.  Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy.

Authors:  Pascale Richard; Philippe Charron; Lucie Carrier; Céline Ledeuil; Theary Cheav; Claire Pichereau; Abdelaziz Benaiche; Richard Isnard; Olivier Dubourg; Marc Burban; Jean-Pierre Gueffet; Alain Millaire; Michel Desnos; Ketty Schwartz; Bernard Hainque; Michel Komajda
Journal:  Circulation       Date:  2003-04-21       Impact factor: 29.690

8.  Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.

Authors:  B J Maron; S A Casey; L C Poliac; T E Gohman; A K Almquist; D M Aeppli
Journal:  JAMA       Date:  1999-02-17       Impact factor: 56.272

9.  Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis.

Authors:  A Woo; H Rakowski; J C Liew; M-S Zhao; C-C Liew; T G Parker; M Zeller; E D Wigle; M J Sole
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

10.  Clinical course of hypertrophic cardiomyopathy with survival to advanced age.

Authors:  Barry J Maron; Susan A Casey; Robert G Hauser; Dorothee M Aeppli
Journal:  J Am Coll Cardiol       Date:  2003-09-03       Impact factor: 24.094

View more
  48 in total

1.  Converter domain mutations in myosin alter structural kinetics and motor function.

Authors:  Laura K Gunther; John A Rohde; Wanjian Tang; Shane D Walton; William C Unrath; Darshan V Trivedi; Joseph M Muretta; David D Thomas; Christopher M Yengo
Journal:  J Biol Chem       Date:  2018-12-05       Impact factor: 5.157

2.  Deciphering the super relaxed state of human β-cardiac myosin and the mode of action of mavacamten from myosin molecules to muscle fibers.

Authors:  Robert L Anderson; Darshan V Trivedi; Saswata S Sarkar; Marcus Henze; Weikang Ma; Henry Gong; Christopher S Rogers; Joshua M Gorham; Fiona L Wong; Makenna M Morck; Jonathan G Seidman; Kathleen M Ruppel; Thomas C Irving; Roger Cooke; Eric M Green; James A Spudich
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-13       Impact factor: 11.205

Review 3.  Towards precision medicine.

Authors:  Euan A Ashley
Journal:  Nat Rev Genet       Date:  2016-08-16       Impact factor: 53.242

Review 4.  Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.

Authors:  Ali J Marian; Eugene Braunwald
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

5.  The mesa trail and the interacting heads motif of myosin II.

Authors:  John L Woodhead; Roger Craig
Journal:  Arch Biochem Biophys       Date:  2019-12-13       Impact factor: 4.013

6.  Overview of Specifications to the ACMG/AMP Variant Interpretation Guidelines.

Authors:  Steven M Harrison; Leslie G Biesecker; Heidi L Rehm
Journal:  Curr Protoc Hum Genet       Date:  2019-09

Review 7.  Morphomechanic phenotypic variability of sarcomeric cardiomyopathies: A multifactorial polygenic perspective.

Authors:  Ares Pasipoularides
Journal:  J Mol Cell Cardiol       Date:  2018-11-10       Impact factor: 5.000

8.  The myosin mesa and the basis of hypercontractility caused by hypertrophic cardiomyopathy mutations.

Authors:  Suman Nag; Darshan V Trivedi; Saswata S Sarkar; Arjun S Adhikari; Margaret S Sunitha; Shirley Sutton; Kathleen M Ruppel; James A Spudich
Journal:  Nat Struct Mol Biol       Date:  2017-05-08       Impact factor: 15.369

9.  Integrated structural and evolutionary analysis reveals common mechanisms underlying adaptive evolution in mammals.

Authors:  Greg Slodkowicz; Nick Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

10.  Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models.

Authors:  Styliani Vakrou; Ryuya Fukunaga; D Brian Foster; Lars Sorensen; Yamin Liu; Yufan Guan; Kirubel Woldemichael; Roberto Pineda-Reyes; Ting Liu; Jill C Tardiff; Leslie A Leinwand; Carlo G Tocchetti; Theodore P Abraham; Brian O'Rourke; Miguel A Aon; M Roselle Abraham
Journal:  JCI Insight       Date:  2018-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.